{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:20:04Z","timestamp":1781932804157,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok","doi-asserted-by":"publisher","award":["PD112960"],"award-info":[{"award-number":["PD112960"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HA4348\/2-2"],"award-info":[{"award-number":["HA4348\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1431-x","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T10:02:45Z","timestamp":1562320965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["The PPAR\u03b3 agonist pioglitazone prevents TGF-\u03b2 induced renal fibrosis by repressing EGR-1 and STAT3"],"prefix":"10.1186","volume":"20","author":[{"given":"\u00c1gnes","family":"N\u00e9meth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s M.","family":"M\u00f3zes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Calvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0345-6914","authenticated-orcid":false,"given":"G\u00e1bor","family":"K\u00f6k\u00e9ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/kisup.2013.79","volume":"3","author":"R Kazancioglu","year":"2013","unstructured":"Kazancioglu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011). 2013;3:368\u201371.","journal-title":"Kidney Int Suppl (2011)"},{"key":"1431_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massague","year":"1998","unstructured":"Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753\u201391.","journal-title":"Annu Rev Biochem"},{"key":"1431_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816\u201327.","journal-title":"FASEB J"},{"key":"1431_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","volume":"9","author":"M Karin","year":"1997","unstructured":"Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol. 1997;9:240\u20136.","journal-title":"Curr Opin Cell Biol"},{"key":"1431_CR5","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1073\/pnas.92.7.2572","volume":"92","author":"N Sanderson","year":"1995","unstructured":"Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995;92:2572\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1431_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12882-017-0626-2","volume":"18","author":"MM Mozes","year":"2017","unstructured":"Mozes MM, Szoleczky P, Rosivall L, Kokeny G. Sustained hyperosmolarity increses TGF-ss1 and Egr-1 expression in the rat renal medulla. BMC Nephrol. 2017;18:209.","journal-title":"BMC Nephrol"},{"key":"1431_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/path.4131","volume":"229","author":"S Bhattacharyya","year":"2013","unstructured":"Bhattacharyya S, Fang F, Tourtellotte W, Varga J. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol. 2013;229:286\u201397.","journal-title":"J Pathol"},{"key":"1431_CR8","doi-asserted-by":"publisher","first-page":"F762","DOI":"10.1152\/ajprenal.00181.2005","volume":"290","author":"MB Marrero","year":"2006","unstructured":"Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC. Role of the JAK\/STAT signaling pathway in diabetic nephropathy. Am J Physiol Renal Physiol. 2006;290:F762\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1431_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0961203307079618","volume":"16","author":"L Martinez-Lostao","year":"2007","unstructured":"Martinez-Lostao L, Ordi-Ros J, Balada E, Segarra-Medrano A, Majo-Masferrer J, Labrador-Horrillo M, Vilardell-Tarres M. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis. Lupus. 2007;16:483\u20138.","journal-title":"Lupus"},{"key":"1431_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jss.2012.06.050","volume":"178","author":"F Matsui","year":"2012","unstructured":"Matsui F, Meldrum KK. The role of the Janus kinase family\/signal transducer and activator of transcription signaling pathway in fibrotic renal disease. J Surg Res. 2012;178:339\u201345.","journal-title":"J Surg Res"},{"key":"1431_CR11","doi-asserted-by":"publisher","first-page":"24724","DOI":"10.1074\/jbc.M312006200","volume":"279","author":"Y Kalechman","year":"2004","unstructured":"Kalechman Y, Gafter U, Weinstein T, Chagnac A, Freidkin I, Tobar A, Albeck M, Sredni B. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J Biol Chem. 2004;279:24724\u201332.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"1431_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/bj3420231","volume":"342","author":"JS Huang","year":"1999","unstructured":"Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC, Chuang LY. Role of the Janus kinase (JAK)\/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Biochem J. 1999;342(Pt 1):231\u20138.","journal-title":"Biochem J"},{"key":"1431_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/01.ASN.0000109672.83594.02","volume":"15","author":"H Nakajima","year":"2004","unstructured":"Nakajima H, Takenaka M, Kaimori JY, Hamano T, Iwatani H, Sugaya T, Ito T, Hori M, Imai E. Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol. 2004;15:276\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"1431_CR14","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","volume":"25","author":"H Ogata","year":"2006","unstructured":"Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006;25:2520\u201330.","journal-title":"Oncogene"},{"key":"1431_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1440-1797.2007.00881.x","volume":"12","author":"M Kuratsune","year":"2007","unstructured":"Kuratsune M, Masaki T, Hirai T, Kiribayashi K, Yokoyama Y, Arakawa T, Yorioka N, Kohno N. Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction. Nephrology (Carlton). 2007;12:565\u201371.","journal-title":"Nephrology (Carlton)"},{"key":"1431_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cmet.2017.03.011","volume":"25","author":"L Calvier","year":"2017","unstructured":"Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, Jonigk D, Mozes MM, Hansmann G. PPARgamma links BMP2 and TGFbeta1 pathways in vascular smooth muscle cells, regulating cell proliferation and glucose metabolism. Cell Metab. 2017;25:1118\u20131134 e1117.","journal-title":"Cell Metab"},{"key":"1431_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/VHRM.S993","volume":"4","author":"F Chiarelli","year":"2008","unstructured":"Chiarelli F, Di Marzio D. Peroxisome proliferator-activated receptor-gamma agonists and diabetes: current evidence and future perspectives. Vasc Health Risk Manag. 2008;4:297\u2013304.","journal-title":"Vasc Health Risk Manag"},{"key":"1431_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","volume":"374","author":"WN Kernan","year":"2016","unstructured":"Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016;374:1321\u201331.","journal-title":"N Engl J Med"},{"key":"1431_CR19","first-page":"62641","volume":"2007","author":"W Wang","year":"2007","unstructured":"Wang W, Liu F, Chen N. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediat Inflamm. 2007;2007:62641.","journal-title":"Mediat Inflamm"},{"key":"1431_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/labinvest.2008.104","volume":"89","author":"T Kawai","year":"2009","unstructured":"Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Investig. 2009;89:47\u201358.","journal-title":"Lab Investig"},{"key":"1431_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11596-016-1539-1","volume":"36","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang J, Zhou QD, Zhang CH, Li Q, Huang S, Zhan J, Wang K, Liu YY, Xu G. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice. J Huazhong Univ Sci Technolog Med Sci. 2016;36:41\u20137.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"1431_CR22","first-page":"991","volume":"74","author":"JB Kopp","year":"1996","unstructured":"Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Investig. 1996;74:991\u20131003.","journal-title":"Lab Investig"},{"key":"1431_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10125-3","volume":"7","author":"S Czirok","year":"2017","unstructured":"Czirok S, Fang L, Radovits T, Szabo G, Szenasi G, Rosivall L, Merkely B, Kokeny G. Cinaciguat ameliorates glomerular damage by reducing ERK1\/2 activity and TGF-ss expression in type-1 diabetic rats. Sci Rep. 2017;7:11218.","journal-title":"Sci Rep"},{"key":"1431_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bph.14153","volume":"175","author":"MJ Curtis","year":"2018","unstructured":"Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, Hoyer D, Insel PA, Izzo AA, Ji Y, et al. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol. 2018;175:987\u201393.","journal-title":"Br J Pharmacol"},{"key":"1431_CR25","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1172\/JCI42004","volume":"120","author":"A Viau","year":"2010","unstructured":"Viau A, El Karoui K, Laouari D, Burtin M, Nguyen C, Mori K, Pillebout E, Berger T, Mak TW, Knebelmann B, et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest. 2010;120:4065\u201376.","journal-title":"J Clin Invest"},{"key":"1431_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio RE, Chen ER, Lazar MA. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 2014;20:573\u201391.","journal-title":"Cell Metab"},{"key":"1431_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MNH.0b013e32834de526","volume":"21","author":"J Yang","year":"2012","unstructured":"Yang J, Zhou Y, Guan Y. PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens. 2012;21:97\u2013105.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1431_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/CIRCULATIONAHA.106.663120","volume":"115","author":"G Hansmann","year":"2007","unstructured":"Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007;115:1275\u201384.","journal-title":"Circulation"},{"key":"1431_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev.cb.04.110188.001151","volume":"4","author":"JA McDonald","year":"1988","unstructured":"McDonald JA. Extracellular matrix assembly. Annu Rev Cell Biol. 1988;4:183\u2013207.","journal-title":"Annu Rev Cell Biol"},{"key":"1431_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1146\/annurev.biochem.77.032207.120833","volume":"78","author":"MD Shoulders","year":"2009","unstructured":"Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem. 2009;78:929\u201358.","journal-title":"Annu Rev Biochem"},{"key":"1431_CR31","first-page":"154","volume":"68","author":"K Yoshioka","year":"1993","unstructured":"Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S. Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Investig. 1993;68:154\u201363.","journal-title":"Lab Investig"},{"key":"1431_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006;69:213\u20137.","journal-title":"Kidney Int"},{"key":"1431_CR33","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","volume":"59","author":"LJ Ma","year":"2001","unstructured":"Ma LJ, Marcantoni C, Linton MF, Fazio S, Fogo AB. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int. 2001;59:1899\u2013910.","journal-title":"Kidney Int"},{"key":"1431_CR34","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1681\/ASN.2005090983","volume":"17","author":"A Benigni","year":"2006","unstructured":"Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Garofano E, Rottoli D, Ito T, et al. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. J Am Soc Nephrol. 2006;17:1624\u201332.","journal-title":"J Am Soc Nephrol"},{"key":"1431_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000072088","volume":"23","author":"A Sivarajah","year":"2003","unstructured":"Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, Stewart KN, Mota-Filipe H, Cuzzocrea S, Thiemermann C. Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia\/reperfusion injury. Am J Nephrol. 2003;23:267\u201376.","journal-title":"Am J Nephrol"},{"key":"1431_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199\u2013210.","journal-title":"J Pathol"},{"key":"1431_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ki.1992.81","volume":"41","author":"AB Roberts","year":"1992","unstructured":"Roberts AB, McCune BK, Sporn MB. TGF-beta: regulation of extracellular matrix. Kidney Int. 1992;41:557\u20139.","journal-title":"Kidney Int"},{"key":"1431_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2353\/ajpath.2009.080574","volume":"174","author":"M Wu","year":"2009","unstructured":"Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol. 2009;174:519\u201333.","journal-title":"Am J Pathol"},{"key":"1431_CR39","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00467-009-1163-4","volume":"24","author":"Y Liang","year":"2009","unstructured":"Liang Y, Jin Y, Li Y. Expression of JAKs\/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis. Pediatr Nephrol. 2009;24:1661\u201371.","journal-title":"Pediatr Nephrol"},{"key":"1431_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/ki.2010.154","volume":"78","author":"M Pang","year":"2010","unstructured":"Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, Chin YE, Yan H, Dworkin LD, Zhuang S. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010;78:257\u201368.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1431-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1431-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:13:48Z","timestamp":1593818028000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1431-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1431-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"13 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures and handling of animals during the investigations were reviewed and approved by the local Ethical Committee for Animal Experimentation at Semmelweis University and the Directorate of Food Chain Safety and Animal Health of the Pest County Government Office (permission number PE\/EA\/948\u20134\/2018) according to the EU Directive 2010\/63\/EU for animal experiments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests. The results presented in this paper have not been published previously in whole or part, except in abstract form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}